Czechia· CZ-0272072
VYVGART
A efgartigimod alfa product containing efgartigimod alfa, registered in Czechia by argenx BV, Gent. The same ATC class is registered in 7 of our 19 countries.
Checked against SÚKL (Czech Republic) on
Informational only — not a medical device.
Where it is registered
Efgartigimod alfa is registered in 7 of 19 countries.
Countries holding a registration under ATC L04AL01 (efgartigimod alfa), each read from that country’s own register.
- This record: Czechia, from SÚKL (Czech Republic)
- 5 of them publish a price we can compare per daily dose
Efgartigimod alfa · ATC L04AL01
7 / 19 countries
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
SÚKL (Czech Republic)- Active substance
- EFGARTIGIMOD ALFA
- Manufacturer
- argenx BV, Gent
- Country
- Czechia (CZ)
- ATC code
- L04AL01
- ATC class
- Efgartigimod alfa
- Defined daily dose
- 4 g, P
- Reimbursed
- Not published by this register
- Source register
- SÚKL (Czech Republic)
- Last checked
- September 28, 2026
Packs & prices · 1
1 priced- cz_kod_sukl02720721X5,6MLCZK 386124.84
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Efgartigimod alfa in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- PolandVyvgartargenx BV
- SwedenVyvgart 1000 mg Injektionsvätska, lösningArgenx
- BelgiumVyvgart 1000 mgArgenx
- IcelandVyvgartArgenx BV
- SwitzerlandVyvgart 1000 mg/ 5 ml, solution injectable en seringue préremplieargenx Switzerland SA
- SpainVYVGART 1.000 MG SOLUCION INYECTABLEArgenx B.V.
- FinlandVyvgartArgenx
- FranceVYVGART 1 000 mg, solution injectable en seringue préremplieARGENX (BELGIQUE)
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Vyvgart
- Liechtenstein · Vyvgart
- Norway · Vyvgart
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/92e7c3f4-35b6-4453-bed2-ec90a02e92ea GET /v1/drugs/92e7c3f4-35b6-4453-bed2-ec90a02e92ea?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "INJ SOL",
"source": "sukl",
"strength": "1000MG",
"pack_size": "1X5,6ML",
"substance": "EFGARTIGIMOD ALFA",
"cz_kod_sukl": "0272072",
"product_type": "IM/BT",
"substance_codes": "21332",
"registration_state": "R",
"registration_number": "EU/1/22/1674/002"
}See everything about efgartigimod alfa.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.